Glc-PC, a new type of glucosidic phospholipid

Angewandte Chemie (International Edition in English)

Volumn 34, Issue 23, 1996, Pages 2667-2669

  Mickeleit, Michael ^a   Wieder, Thomas ^b   Buchner, Klaus ^c   Geilen, Christoph ^b   Mulzer, Johann ^a   Reutter, Werner ^b  

^a GOETHE UNIVERSITY   (Germany)

^b Inst Molekularbiologie B   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Glyceraldehyde; Glycosidations; Phospholipids; Proliferation inhibitors; Protein kinase C

Indexed keywords

EID: 33751143880     PISSN: 05700833     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. D. E. Vance, Biochem. Cell Biol. 1990, 68, 1151-1165; S. H. Exton, J. Biol. Chem. 1990, 265, 1-4; S. H. Zeisel, FASEB J. 1993, 7, 551-557.
2. D. E. Vance, Biochem. Cell Biol. 1990, 68, 1151-1165; S. H. Exton, J. Biol. Chem. 1990, 265, 1-4; S. H. Zeisel, FASEB J. 1993, 7, 551-557.
3. D. E. Vance, Biochem. Cell Biol. 1990, 68, 1151-1165; S. H. Exton, J. Biol. Chem. 1990, 265, 1-4; S. H. Zeisel, FASEB J. 1993, 7, 551-557.
4. P. C. Choy, D. E. Vance, J. Biol. Chem. 1978, 253, 5163-5167; K. Oishi, R. L. Raynor, P. A. Charp, J. F. Kuo, ibid. 1988, 263(14), 6865-6871; C. C. Geilen, T. Wieder, W. Reutter, ibid. 1992, 267, 6719-6724; M. Mosior, R. M. Epand, Biochemistry 1993, 32, 66-75; C. C. Geilen, A. Haase, T. Wieder, D. Arndt, R. Zeisig, W. Reutter, J. Lipid Res. 1994, 35, 625-632.
5. P. C. Choy, D. E. Vance, J. Biol. Chem. 1978, 253, 5163-5167; K. Oishi, R. L. Raynor, P. A. Charp, J. F. Kuo, ibid. 1988, 263(14), 6865-6871; C. C. Geilen, T. Wieder, W. Reutter, ibid. 1992, 267, 6719-6724; M. Mosior, R. M. Epand, Biochemistry 1993, 32, 66-75; C. C. Geilen, A. Haase, T. Wieder, D. Arndt, R. Zeisig, W. Reutter, J. Lipid Res. 1994, 35, 625-632.
6. P. C. Choy, D. E. Vance, J. Biol. Chem. 1978, 253, 5163-5167; K. Oishi, R. L. Raynor, P. A. Charp, J. F. Kuo, ibid. 1988, 263(14), 6865-6871; C. C. Geilen, T. Wieder, W. Reutter, ibid. 1992, 267, 6719-6724; M. Mosior, R. M. Epand, Biochemistry 1993, 32, 66-75; C. C. Geilen, A. Haase, T. Wieder, D. Arndt, R. Zeisig, W. Reutter, J. Lipid Res. 1994, 35, 625-632.
7. P. C. Choy, D. E. Vance, J. Biol. Chem. 1978, 253, 5163-5167; K. Oishi, R. L. Raynor, P. A. Charp, J. F. Kuo, ibid. 1988, 263(14), 6865-6871; C. C. Geilen, T. Wieder, W. Reutter, ibid. 1992, 267, 6719-6724; M. Mosior, R. M. Epand, Biochemistry 1993, 32, 66-75; C. C. Geilen, A. Haase, T. Wieder, D. Arndt, R. Zeisig, W. Reutter, J. Lipid Res. 1994, 35, 625-632.
8. P. C. Choy, D. E. Vance, J. Biol. Chem. 1978, 253, 5163-5167; K. Oishi, R. L. Raynor, P. A. Charp, J. F. Kuo, ibid. 1988, 263(14), 6865-6871; C. C. Geilen, T. Wieder, W. Reutter, ibid. 1992, 267, 6719-6724; M. Mosior, R. M. Epand, Biochemistry 1993, 32, 66-75; C. C. Geilen, A. Haase, T. Wieder, D. Arndt, R. Zeisig, W. Reutter, J. Lipid Res. 1994, 35, 625-632.
9. H. U. Weltzien, O. Westphal, Liebigs Ann. Chem. 1967, 709, 240-243; R. Andreesen, M. Modolell, H. U. Weltzien, H. Eibl, H. H. Common, G. W. Lör, P. G. Munder, Cancer Res. 1978, 38, 3894-3899; W. E. Berdel, W. R. E. Bausert, V. Fink, J. Rastetter, P. G. Munder, Anticancer Res. 1981, 1, 345-352; C. C. Geilen, R. Haase, K. Buchner, T. Wieder, F. Hucho, W. Reutter, Eur. J. Cancer 1991, 27, 1650-1653.
10. H. U. Weltzien, O. Westphal, Liebigs Ann. Chem. 1967, 709, 240-243; R. Andreesen, M. Modolell, H. U. Weltzien, H. Eibl, H. H. Common, G. W. Lör, P. G. Munder, Cancer Res. 1978, 38, 3894-3899; W. E. Berdel, W. R. E. Bausert, V. Fink, J. Rastetter, P. G. Munder, Anticancer Res. 1981, 1, 345-352; C. C. Geilen, R. Haase, K. Buchner, T. Wieder, F. Hucho, W. Reutter, Eur. J. Cancer 1991, 27, 1650-1653.
11. H. U. Weltzien, O. Westphal, Liebigs Ann. Chem. 1967, 709, 240-243; R. Andreesen, M. Modolell, H. U. Weltzien, H. Eibl, H. H. Common, G. W. Lör, P. G. Munder, Cancer Res. 1978, 38, 3894-3899; W. E. Berdel, W. R. E. Bausert, V. Fink, J. Rastetter, P. G. Munder, Anticancer Res. 1981, 1, 345-352; C. C. Geilen, R. Haase, K. Buchner, T. Wieder, F. Hucho, W. Reutter, Eur. J. Cancer 1991, 27, 1650-1653.
12. H. U. Weltzien, O. Westphal, Liebigs Ann. Chem. 1967, 709, 240-243; R. Andreesen, M. Modolell, H. U. Weltzien, H. Eibl, H. H. Common, G. W. Lör, P. G. Munder, Cancer Res. 1978, 38, 3894-3899; W. E. Berdel, W. R. E. Bausert, V. Fink, J. Rastetter, P. G. Munder, Anticancer Res. 1981, 1, 345-352; C. C. Geilen, R. Haase, K. Buchner, T. Wieder, F. Hucho, W. Reutter, Eur. J. Cancer 1991, 27, 1650-1653.
13. C. Unger, H. Eibl, H. W. von Heyden, M. Peukert, H. Sindermann, G. A. Nagel, Onkologie 1990, 13, 56.
14. J. Mulzer, A. Angermann, Tetrahedron Lett. 1983, 24, 2843-2846; J. Jurczak, S. Pikul, T. Bauer, ibid. 1986, 42, 447-488; J. Mann, N. K. Partlett, A. Thomas, J. Chem. Res. 1987, 369.
15. J. Mulzer, A. Angermann, Tetrahedron Lett. 1983, 24, 2843-2846; J. Jurczak, S. Pikul, T. Bauer, ibid. 1986, 42, 447-488; J. Mann, N. K. Partlett, A. Thomas, J. Chem. Res. 1987, 369.
16. J. Mulzer, A. Angermann, Tetrahedron Lett. 1983, 24, 2843-2846; J. Jurczak, S. Pikul, T. Bauer, ibid. 1986, 42, 447-488; J. Mann, N. K. Partlett, A. Thomas, J. Chem. Res. 1987, 369.
17. T. Mukaiyama, Y. Murai, S. Shoda, Chem. Lett. 1981, 431-432.
18. G. H. Posner, S. H. Haines, Tetrahedron Lett. 1985, 26, 5-8.
19. The use of benzyl protective groups is essential. The acetates, which are commonly used in sugar chemistry, give only small yields.
20. B. C. Ranu, Synlett 1993, 885-892; W. J. Gensler, F. A. Johnson, A. D. B. Sloan, J. Am. Chem. Soc. 1960, 82, 6074-6079.
21. B. C. Ranu, Synlett 1993, 885-892; W. J. Gensler, F. A. Johnson, A. D. B. Sloan, J. Am. Chem. Soc. 1960, 82, 6074-6079.
22. G. Hirth, H. Saroka, W. Bannwarth, R. Barner, Helv. Chim. Acta 1983, 66, 1210-1240.
23. 2, 4:1). The final product is the pure α-anomer.
24. M. J. Clemens, I. Trayner, J. Menaya, J. Cell Sci. 1992, 103, 881-887; Y. Nishizuka, Science 1992, 258, 607-614.
25. M. J. Clemens, I. Trayner, J. Menaya, J. Cell Sci. 1992, 103, 881-887; Y. Nishizuka, Science 1992, 258, 607-614.
26. K. Oishi, R. L. Raynor, P. A. Charp, J. F. Kuo, J. Biol. Chem. 1988, 263(14), 6865-6871.
27. The basal activity was measured without addition of phosphatidylserin/ diolein.
28. P. Boukamp, R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, N. E. Fusenig, J. Cell Biol. 1988, 106, 761-771.
29. The spontaneously immortalized human keratinocyte cell line HaCaT ([14]) was kindly provided by Dr. N. E. Fusenig (DKFZ Heidelberg, Germany).
30. J. G. Culvenor, A. W. Harris, T. E. Mandel, A. Whitelaw, E. Ferber, J. Immunol. 1981, 126, 1974-1977.
31. R. J. Gillies, N. Didier, M. Denton, Anal. Biochem. 1986, 159, 109-113.
32. C. C. Geilen, R. Haase, K. Buchner, T. Wieder, F. Hucho, W. Reutter, Eur. J. Cancer 1991, 27, 1650-1653.
33. H. Krüger, W. Schröder, K. Buchner, F. Hucho, J. Protein Chem. 1990, 9, 467-473.
34. Since the substrate is histone, the measured activity is due predominantly to the "classical" isoforms of protein kinase C (α, β, γ). The test system consists of purified components only and contains no other enzymes besides PKS. A role for Glc-PC as a prodrug with respect to 2-lysophosphatidylcholine (LPC) can thus be ruled out.
35. M. Liyanage, D. Frith, E. Livneh, S. Stabels, Biochem. J. 1992, 283, 781-787.